The IND is not approved right away by the FDA, sponsor must wait 1 __ following the filing of the application. If during the initial 30 day period, the FDA has some safety concerns regarding initiating the clinical studies, it will issue a 2 __. Trials in human may not begin until the sponsor has resolved those safety concerns and the clinical hold has been lifted.